{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:37:16Z","timestamp":1782995836083,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41401-019-0244-6","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T08:55:20Z","timestamp":1561366520000},"page":"1555-1567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy"],"prefix":"10.1038","volume":"40","author":[{"given":"Qian","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"244_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11892-006-0083-y","volume":"6","author":"P Rossing","year":"2006","unstructured":"Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep. 2006;6:479\u201383.","journal-title":"Curr Diab Rep"},{"key":"244_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","volume":"6","author":"YS Kanwar","year":"2011","unstructured":"Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol. 2011;6:395\u2013423.","journal-title":"Annu Rev Pathol"},{"key":"244_CR3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ki.5002180","volume":"71","author":"MS Simonson","year":"2007","unstructured":"Simonson MS. Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney Int. 2007;71:846\u201354.","journal-title":"Kidney Int"},{"key":"244_CR4","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776\u201384.","journal-title":"J Clin Invest"},{"key":"244_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1681\/ASN.2008121226","volume":"21","author":"Y Liu","year":"2010","unstructured":"Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21:212\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"244_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/iub.1579","volume":"68","author":"K Switon","year":"2016","unstructured":"Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Tuberous sclerosis complex: from molecular biology to novel therapeutic approaches. IUBMB Life. 2016;68:955\u201362.","journal-title":"IUBMB Life"},{"issue":"Suppl 1","key":"244_CR7","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.diabres.2008.09.028","volume":"82","author":"K Inoki","year":"2008","unstructured":"Inoki K. Role of TSC-mTOR pathway in diabetic nephropathy. Diabetes Res Clin Pract. 2008;82(Suppl 1):S59\u201362.","journal-title":"Diabetes Res Clin Pract"},{"key":"244_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/B978-0-444-64076-5.00052-1","volume":"148","author":"DM Hasbani","year":"2018","unstructured":"Hasbani DM, Crino PB. Tuberous sclerosis complex. Handb Clin Neurol. 2018;148:813\u201322.","journal-title":"Handb Clin Neurol"},{"key":"244_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002;4:648\u201357.","journal-title":"Nat Cell Biol"},{"key":"244_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005;121:179\u201393.","journal-title":"Cell"},{"key":"244_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.pharmtox.47.120505.105359","volume":"47","author":"CH Lee","year":"2007","unstructured":"Lee CH, Inoki K, Guan KL. mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharm Toxicol. 2007;47:443\u201367.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"244_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115:577\u201390.","journal-title":"Cell"},{"key":"244_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdermsci.2015.04.005","volume":"79","author":"M Wataya-Kaneda","year":"2015","unstructured":"Wataya-Kaneda M. Mammalian target of rapamycin and tuberous sclerosis complex. J Dermatol Sci. 2015;79:93\u2013100.","journal-title":"J Dermatol Sci"},{"key":"244_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2015.01.026","volume":"32","author":"A Thien","year":"2015","unstructured":"Thien A, Prentzell MT, Holzwarth B, Kl\u00e4sener K, Kuper I, Boehlke C, et al. TSC1 activates TGF-\u03b2-Smad2\/3 signaling in growth arrest and epithelial-to-mesenchymal transition. Dev Cell. 2015;32:617\u201330.","journal-title":"Dev Cell"},{"key":"244_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.2353\/ajpath.2010.090233","volume":"177","author":"EA Barnes","year":"2010","unstructured":"Barnes EA, Kenerson HL, Jiang X, Yeung RS. Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition. Am J Pathol. 2010;177:1765\u201378.","journal-title":"Am J Pathol"},{"key":"244_CR16","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1681\/ASN.2012030285","volume":"23","author":"SL Habib","year":"2012","unstructured":"Habib SL, Yadav M, Tizani S, Bhandari B, Valente AJ. Tuberin inhibits production of the matrix protein fibronectin in diabetes. J Am Soc Nephrol. 2012;23:1652\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"244_CR17","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1681\/ASN.2015010032","volume":"27","author":"Y Yao","year":"2016","unstructured":"Yao Y, Wang J, Yoshida S, Nada S, Okada M, Inoki K. Role of ragulator in the regulation of mechanistic target of rapamycin signaling in podocytes and glomerular function. J Am Soc Nephrol. 2016;27:3653\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bbadis.2013.02.022","volume":"1832","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Li BY, Li XL, Cheng M, Yu F, Lu WD, et al. Proteomic analysis of kidney and protective effects of grape seed procyanidin B2 in db\/db mice indicate MFG-E8 as a key molecule in the development of diabetic nephropathy. Biochim Biophys Acta. 2013;1832:805\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"244_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2015.06.006","volume":"99","author":"Q Lu","year":"2015","unstructured":"Lu Q, Ji XJ, Zhou YX, Yao XQ, Liu YQ, Zhang F, et al. Quercetin inhibits the mTORC1\/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. Pharm Res. 2015;99:237\u201347.","journal-title":"Pharm Res"},{"key":"244_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.urology.2015.12.009","volume":"89","author":"A Kapoor","year":"2016","unstructured":"Kapoor A, Girard L, Lattouf JB, Pei Y, Rendon R, Card P, et al. Evolving strategies in the treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML). Urology. 2016;89:19\u201326.","journal-title":"Urology"},{"key":"244_CR21","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.3928\/19382359-20170320-01","volume":"46","author":"SC Randle","year":"2017","unstructured":"Randle SC. Tuberous sclerosis complex: a review. Pediatr Ann. 2017;46:e166\u2013e171.","journal-title":"Pediatr Ann"},{"key":"244_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pedhc.2006.05.004","volume":"21","author":"AK Leung","year":"2007","unstructured":"Leung AK, Robson WL. Tuberous sclerosis complex: a review. J Pediatr Health Care. 2007;21:108\u201314.","journal-title":"J Pediatr Health Care"},{"key":"244_CR23","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1016\/j.ajpath.2016.08.013","volume":"186","author":"S Ren","year":"2016","unstructured":"Ren S, Luo Y, Chen H, Warburton D, Lam HC, Wang LL, et al. Inactivation of Tsc2 in mesoderm-derived cells causes polycystic kidney lesions and impairs lung alveolarization. Am J Pathol. 2016;186:3261\u201372.","journal-title":"Am J Pathol"},{"key":"244_CR24","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1093\/hmg\/ddp398","volume":"18","author":"J Zhou","year":"2009","unstructured":"Zhou J, Brugarolas J, Parada LF. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. Hum Mol Genet. 2009;18:4428\u201341.","journal-title":"Hum Mol Genet"},{"key":"244_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00441-011-1227-1","volume":"347","author":"RM Carew","year":"2012","unstructured":"Carew RM, Wang B, Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res. 2012;347:103\u201316.","journal-title":"Cell Tissue Res"},{"key":"244_CR26","first-page":"131","volume":"22","author":"CE Hills","year":"2011","unstructured":"Hills CE, Squires PE. The role of TGF-\u03b2 and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011;22:131\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"key":"244_CR27","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-13-1256","volume":"74","author":"A Tyryshkin","year":"2014","unstructured":"Tyryshkin A, Bhattacharya A, Eissa NT. SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis. Cancer Res. 2014;74:1996\u20132005.","journal-title":"Cancer Res"},{"key":"244_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/15680096113136660102","volume":"13","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shi J, Chai K, Ying X, Zhou BP. The role of Snail in EMT and tumorigenesis. Curr Cancer Drug Targets. 2013;13:963\u201372.","journal-title":"Curr Cancer Drug Targets"},{"key":"244_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","volume":"14","author":"S Ansieau","year":"2008","unstructured":"Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14:79\u201389.","journal-title":"Cancer Cell"},{"key":"244_CR30","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1172\/JCI44771","volume":"121","author":"K Inoki","year":"2011","unstructured":"Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest. 2011;121:2181\u201396.","journal-title":"J Clin Invest"},{"key":"244_CR31","doi-asserted-by":"publisher","first-page":"E975","DOI":"10.3390\/ijms17060975","volume":"17","author":"M Kajiwara","year":"2016","unstructured":"Kajiwara M, Masuda S. Role of mTOR inhibitors in kidney disease. Int J Mol Sci. 2016;17:E975.","journal-title":"Int J Mol Sci"},{"key":"244_CR32","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1681\/ASN.2004100894","volume":"16","author":"JK Chen","year":"2005","unstructured":"Chen JK, Chen J, Neilson EG, Harris RC. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol. 2005;16:1384\u201391.","journal-title":"J Am Soc Nephrol"},{"key":"244_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.phymed.2015.08.010","volume":"22","author":"Q Lu","year":"2015","unstructured":"Lu Q, Zuo WZ, Ji XJ, Zhou YX, Liu YQ, Yao XQ, et al. Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt\/mTOR signaling in diabetic nephropathy. Phytomedicine. 2015;22:1071\u20138.","journal-title":"Phytomedicine"}],"updated-by":[{"DOI":"10.1038\/s41401-021-00785-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000}}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0244-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T19:01:19Z","timestamp":1634151679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0244-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0244-6","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"14 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41401-021-00785-3","URL":"https:\/\/doi.org\/10.1038\/s41401-021-00785-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}